Playback speed
10 seconds
Emerging Therapies for MM: Isatuximab, Daratumumab IV vs. SubQ Formulation, Selinexor / Dexamethasone, Belantamab Mafodotin, and BCMA Targeting
74 views
January 25, 2021
Login to view comments.
Click here to Login